By Adam Lidgett (February 1, 2021, 3:35 PM EST) -- The federal government has agreed to postpone the effective date of parts of the Trump administration's so-called rebate rule, which eliminated Anti-Kickback Statute immunity for drugmaker rebates.
U.S. District Judge John D. Bates on Saturday signed off on an agreement between the Pharmaceutical Care Management Association and the U.S. Department of Health and Human Services to push back provisions of the rule until Jan. 1, 2023. Those provisions were supposed to take effect Jan. 1, 2022, according to court documents.
The parties told the court on Friday that the postponement would best allow the Biden administration's HHS to look over the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!